About Endologix, Inc.

Endologix, Inc. engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA.

At the moment the company generates 166M USD in revenues.

On its last earning announcement, the company reported a loss of -0.82$ per share.

The book value per share is 0.47$

Endologix, Inc. website


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
166M 67.50% -49M -29.60% -68M -0.82 - - 84M 0.47 -34M -1M -35M